On-demand d-modafinil may be an effective treatment option for lifelong premature ejaculation: a case report

Andrologia ◽  
2015 ◽  
Vol 48 (1) ◽  
pp. 121-122 ◽  
Author(s):  
E. C. Serefoglu
Keyword(s):  
Case Report ◽  
Effective Treatment ◽  
Treatment Option ◽  
Premature Ejaculation ◽  
Effective Treatment Option ◽  
On Demand ◽  
Lifelong Premature Ejaculation

Intraventricular Baclofen Therapy as Effective Treatment Option in Kernicterus – A Case Report

2019 ◽  
Author(s):  
Julia Anderl ◽  
Sergy Persits ◽  
Steffen Berweck ◽  
Manfred Kudernatsch ◽  
Gerhard Kluger ◽  
...  
Keyword(s):  
Case Report ◽  
Effective Treatment ◽  
Treatment Option ◽  
Effective Treatment Option

scholarly journals COVID-19 convalescent plasma clears SARS-CoV-2 refractory to remdesivir in an infant with congenital heart disease

2020 ◽  
Vol 4 (18) ◽  
pp. 4278-4281 ◽  
Author(s):  
Zahidee Rodriguez ◽  
Andi L. Shane ◽  
Hans Verkerke ◽  
Christopher Lough ◽  
Matthew G. Zimmerman ◽  
...  
Keyword(s):  
Congenital Heart Disease ◽  
Heart Disease ◽  
Effective Treatment ◽  
Treatment Option ◽  
Congenital Heart ◽  
Effective Treatment Option ◽  
Immune Systems ◽  
Key Points ◽  
Donor Variability

Key Points COVID-19 convalescent plasma (CP) may be a safe and effective treatment option in SARS-CoV-2 infection refractory to remdesivir. Infants may benefit from CP despite developing immune systems and donor variability emphasizes the need for characterization prior to use.

scholarly journals Gentamicin susceptibility among a sample of multi-drug resistantNeisseria gonorrhoeaeisolates in India

2016 ◽  
pp. AAC.01907-16 ◽  
Author(s):  
Manju Bala ◽  
Vikram Singh ◽  
Aradhana Bhargava ◽  
Monika Kakran ◽  
Naveen Chandra Joshi ◽  
...  
Keyword(s):  
Effective Treatment ◽  
Treatment Outcomes ◽  
Treatment Option ◽  
Antimicrobial Susceptibility ◽  
Susceptibility Testing ◽  
Dual Therapy ◽  
Clinical Treatment ◽  
Antimicrobial Susceptibility Testing ◽  
Effective Treatment Option

Antimicrobial susceptibility testing of 258N. gonorrhoeaeisolates by Etest determined that 60.1% were MDR while 5% strains had decreased susceptibility to currently recommended extended-spectrum cephalosporins (ESCs). Among these, 84.5% MDR and 76.9% strains having decreased susceptibility to ESCs were susceptible to gentamicin. No MDR isolate was resistant to gentamicin. Thesein vitroresults suggest that gentamicin might be an effective treatment option for the MDR strains and in dual therapy for gonorrhea. However, further research regarding the clinical treatment outcomes is essential.

Sign in / Sign up

Export Citation Format

Share Document